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ABSTRACT  
 
The determination of tranexamic acid levels in tablets was performed using colorimetry method 
in several studies. Based on its structure, tranexamic acid shows very low UV absorption which 
impacts to the lack of sensitivity. Then, it requires the addition of a chromophore agent to facilitate 
and enhance the detection limit. Recently, FTIR reported has been established as a direct content 
determination for some tablet dosage forms as a specific, simple, and rapid method. In this present 
research, the method’s performance was investigated to quantify tranexamic acid in its tablet dosage 
form directly. The result was compared to a developed colorimetry using ninhydrin reagent. 
Correlations between the two methods were analyzed using t-test. The good linearity was shown at a 
concentration range of 0.5 - 1.75% w/w of NH group’s spectra. Furthermore, the recovery, intra- and 
inter-day precision also have been proven to be fulfilled the validation requirement. Futhermore, LOD 
and LOQ of the method were 0.0531%w/w and 0.1770% w/w respectively. These results were next 
compared with the counterpart. Afterwards, the t-test statistically proved no significant difference of 
content determination yielded, between these two methods. In conclusion, FTIR can be used for 
quantifying the content of tranexamic tablet, than the colorimetry. Moreover, FTIR method also has 
some advantages such as easier, simpler, faster, cheaper and more sensitive than the counterpart 
methods. Finally, this method was suggested as a complementary for tranexamic content determination 
directly of its tablet dosage form. 
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INTRODUCTION 
Tranexamic acid is an antifibrinolytic drug that inhibits the breakdown of fibrin clots by 
blocking the binding of plasminogen and plasmin to fibrin. This drug is used for bleeding, and 
prophylaxis of angioedema (Sweetman, 2009). In the market, there are various forms of tranexamic 
acid preparations, including tablets, ampoules, vials, and capsules. Methods for testing tranexamic acid 
using titration are described in British Pharmacopoeia 2003, European Pharmacopoeia 4th Edition, 
Japan Pharmacopoeia XIV, and Chinese Pharmacopoeia. In addition, there are methods to the 
determination of tranexamic acid in blood and tablets using high-performance liquid chromatography 
(HPLC) and using TLC densitometry (Tampubolon et al., 2005).  
The previous studies showed the determination of tranexamic acid levels in tablets was 
performed using colorimetry method (Anshari et al., 2005, Arayne et al., 2008). It was done based on 
the absorption of compounds in the UV-Vis region which are specific at certain wavelengths. Based on 
its structure, tranexamic acid has very low UV absorption and the lack of sensitivity. It requires the 
addition of a chromophore agent to facilitate and enhance the detection limit.  
Nowadays, infrared spectroscopy commonly is a technique used for qualitative analysis, based 
on the atomic vibrations within a molecule. FTIR is one of it the fastest, most sensitive, and more 
accurate than any other. This is because the data is collected and stored in a digital form inside the 
computer so it can be easily changed, moved, and displayed. Analysis using FTIR was developed to 
overcome other methods that require complicated preparation, such as extraction and dilution. FTIR 
can be used for any sample form (solid, liquid, gas) directly, so that preparation will be easier (Skoog 
et al., 2007).  
However, recently, some previous experiments showed the feasibility of FTIR for tablet's direct 
content determinations. The quantification method of acyclovir in single component tablet (Nugrahani 
and Mussadah, 2016) and vitamin B1 – vitamin B6 in a combination (Nugrahani and Kirana, 2016) 
has been established. The method was supported by a conversion of the absorbance spectrum into its 
mathematics derivative. This procedure has been improved to overcome the lack of specificity of 
infrared quantitative spectroscopy. 
Tranexamic acid has a physical form of white and crystalline powder, soluble both in water and 
in glacial acetic acid. If seen from its structure, tranexamic acid has a primary NH group and C = O, 
which is rarely owned by tablet’s excipients. So it was expected to produce a specific infrared 
spectrum of the active compound which will not be interfered by the common ingredients of the tablet 
matrix. Therefore, it is proper to develop a quantitative analysis using FTIR in a tablet dosage form 
directly.   
Based on the previous information, the purpose of this study was to develop and validate a 
complementary to determine tranexamic acid content in tablets using FTIR. Afterwards, the result will 
be compared to other spectrometry. The colorimetic method has been reported using ninhydrin as the 
chromophore provider (Anshari et al., 2005, Arayne et al., 2008). A new method of analyzing 
tranexamic acid levels was hoped to deserve the better advantages.   
 
MATERIALS AND METHODS   
MATERIALS 
Standard of tranexamic acid (BPOM, Jakarta), tranexamic acid tablets (from the market, 
Bandung), matrix tablet (composed of lactose (Merck), PVP (Merck), magnesium stearate (Merck). 
 
Development of tranexamic acids FTIR method   
Measurement of the standard spectrum of tranexamic acid    
The method was begun with performed a variety of tranexamic acid concentrations in the KBr 
pellets. It then weighed 10 mg of each variation and forged. After the clear pellet resulted, it was 
measured the AUC of a variety concentration in the range of wave numbers 4000 cm-1 to 400 cm-1. 
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The spectrum was converted into an absorbance function of the wave number. The experiment was 
done triple (three times).  
 
Derivation of the standard spectrum of tranexamic acids   
The baseline in the spectrum was corrected after it was converted into an absorbance function. 
Then it was derivatived mathematically using the software involved in the FTIR instrument. Broadly 
defined AUC was formed with at some range of wave numbers.  
 
Determination of the range of FTIR number standard tranexamic acid waves 
After determination of the best wavenumber was done; a serie of tranexamic acid concentration 
plotted towards the AUC derivatives to find the highest linearity value.   
 
Matrix correction of wave range   
The matrix blank was made following a general formulation of tablet base. An overlay was 
performed between the matrix spectrum and the spectrum containing tranexamic acid.  
 
Validation of FTIR methods   
Validation method consists of specificity, linearity, detection limit, quantitation limit, range, 
accuracy, and precision.  
 
Specificity   
An overlay of spectra derivated was arranged between the matrix alone with the matrix mixed 
with active substance. The wave-numbers with the best linearity and was not influenced by matrix 
derivatives was selected.  
 
Linearity   
Six concentrations of tranexamic acid solutions were analyzed, and AUC measurements were 
made using FTIR. Then, the AUCs were plotted into concentrations (% b/b). It will be accepted when r 
≥ 0.999 and the variance coefficient (Vxo) same or less than 2.0% (ICH, 2005).   
 
 Accuracy   
The method used was additions. The tablet sample was crushed as a blank, next measured its 
AUC derivative using FTIR. Latest it's added with tranexamic acid in a vary concentration (% w/w). 
The mixtures were blended  and  added  with  KBr  into 100 mg. A little amount of these mixtures then 
were taken and pressed to make the pellets for FTIR measurements. After the spectrums were 
obtained, the AUC derivatives were measured minus the initial blanks. Accuracy is acceptable when 
recovery is 98-102% (ICH, 2005).  
 
Precision   
The method used is additions. Tablets were crushed as blanks, further measured the AUC 
derivatives using FTIR. Afterwards, 100% tranexamic acid is added. The combination was blended 
and mixed with KBr to 100 mg. Measurements are repeated six times in a day and three days at 
different analysis times. AUC derivatives were measured for repetition of such results minus the initial 
blanks. Precision is acceptable if the SBR is> 2% (ICH, 2005).  
 
Range   
Determination was performed by looking at the upper and lower limits of the concentration used 
in linearity, accuracy, and precision testing.  
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Limit of detection (LOD) and quantization (LOQ)   
LOD = 3 (Sy / x) / b, LOQ = 10 (Sy / x) / b 
 
Sy / x = standard deviation based on the standard deviation blank, the standard deviation of the 
regression line, and the standard intercept y deviation on the regression line.  
b = is the slope of the calibration curve.  
 
Sample level assessment of tranexamic acid tablets using FTIR   
Tranexamic acid tablets from the market, a total of 20 tablets, were weighed and calculated the 
mean. Furthermore, it is made in certain concentrations. The sample was crushed with KBr to 100 mg 
weight. Subsequently, the AUC derivative sample was measured using FTIR and then calculated 
levels. The resulting content is analyzed in conformity with Indonesian pharmacopoeia requirements 
or other compendia requirements.  
 
Determination of sample levels tranexamate tablets use visible spectrophotometric 
spectrophotmetry  
Preparation of tranexamic acid standard stock solutions   
The raw stock solution was made by dissolving 50 mg of standard tranexamic acid in 100 mL of 
distilled water-ethanol 60:40. The solution then was sonicated for 15 minutes.  
 
Sample preparation of tablets  
Twenty tranexamic acid tablets were weighed and ground with a mortar. A total of 50 mg of 
sample was transferred into a 100 ml volumetric flask, dissolved with water-ethanol (60:40). Next it 
was sonicated along 15 minutes, after that added by the same solvent so that the concentration was 500 
μg / mL. This solution was then filtered through Whatman # 41 filter paper. Further dilution was made 
from this stock solution to obtain the required concentration.  
 
Derivatization for colorimetry   
A 1 mL of ninhydrin solution (0.25% w / v in ethanol) and 1 mL of acetate buffer (pH 7) was 
added into the measuring flask and then added a sample of 3-25 μg / mL of tranexamic acid and 
solvent to a limit of 10 mL. The mixture was heated in a waterbath for 30 minutes, until a purple color 
was formed. The solution was cooled to room temperature, next added with ethanol to the limit marker 
(10 mL).  
Maximum wavelength determination was done by making standard solution of tranexamic acid 
with a serie of concentration between 3-25μg / mL. The solutions were measured using a UV-Vis 
spectrophotometer at a wavelength range of 200-800 nm, then determined the maximum wavelength 
(Ansari et al., 2005; Arayne et al., 2008).  
 
Verification of colorimetry methods   
The method verification consists of specificity, linearity, accuracy, precision, detection limits, 
and quantification limits. Specificity testing was performed by made an overlay between the matrix 
with the active substance spectrum. Linearity test was done by making six test solutions with variation 
of concentrations: 3; 6; 9; 12; 15; 18 μg/mL. These were then analyzed using a UV-Vis 
spectrophotometer at the maximum wavelength. Triple measurements were performed. It then made a 
graph between the absorbance with the standard concentration of tranexamic acid and determined its 
linearity.  
Accuracy test was done by making variation of test solution with concentration equal to 3, 9, 
and 15 μg/mL. The measured solution of each triple was next determined percent recovery rate. 
Precision testing was performed by making the test solutions in concentrations equal to 3, 9, and 15 
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μg/mL measured each on the same day, repeated in three different days, then determined the value of 
the coefficient variance. Limit detection and quantification limits are calculated from linearity test 
results.  
 
Result and discussion 
Development of the tranexamic FTIR method   
The derivated spectrum with series concentration is shown in Figure 1. The range of wave 
numbers is 1511.08-1573.63 cm-1, with the highest linearity, r=0.9994 (Table I). The wavelength 
indicates the presence of the NH2 group on the tranexamic acid structure, and after it has been cured 
with a general formulation matrix, no spectra was revealed in the range of the wave numbers. So it can 
be concluded that the range of 1511.08-1573.63 cm-1 (NH group) can be used as the basis for 
quantitative calculation of tranexamic acid level in pharmaceutical preparation.    
 
Validation of FTIR methods  
 
Specificity  
The spectrum results should show the absence of the matrix over the specified wave number 
range of drug. So, this wave number area can be specified to measure the levels of tranexamic acid 
correctly (Figure 2).   
 
Linearity 
The measurement was conducted to the both series concentrations of 0.5-1.75% w/w. It was 
determined over the wave number range 1511.08-1573.63 cm
-1 
(Table 2). Linear regression equation 
for tranexamic acid standard was resulted y=1.3568x-0.0041 with a correlation coefficient of (r) = 
0.9994. The value of the variance coefficient (Vx0) was 1.5802%. Based on these results, the values of 
r> 0.999 and Vx0 less than 2%, which indicated that the method has fulfilled the linearity requirement. 
The graphic shown in Figure 3. 
 
Accuracy 
From the Table III, it can be seen that the resulting yield is within the required range, so this 
method has met the acceptance accuracy.   
 
Precision 
Intraday precision and Interday precision 
Based on the Table IV and V, tranexamic acid meets the inta and inter-day precision 
requirements. 
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Figure 1.  Derivated absorbance spectrum of tranexamic acid at series concentration 
 
Figure 1 shows the linear response of the FTIR at the 3 area of wavenumbers. The ranges and 
values of derivated absorbance related, are listed in the Table I below.  
 
Table I. Concentrations of tranexamic acid standard and AUC derivatives absorbance 
 
Wavelength (cm
-
¹) 
AUC at series concentration 
Coefficient 
Corelation 0.50% 0.75% 1% 1.25% 1.50% 1.75% 
1511.08-1411.64 0.0027 0.0045 0.0070 0.0097 0.0124 0.0152 0.9901 
1573.63-1511.08 0.0030 0.0060 0.0092 0.0128 0.0163 0.0198 0.9994 
1573.63-1623.77 0.0017 0.0036 0.0057 0.0074 0.0091 0.0119 0.9972 
 
The comparison between the wavenumber area linearity then be conducted, which the area at 
1511.08-1573.63 cm
-1
 shows the highest r (regression linear) value: 0.9994. So, this spectra was used 
to further method development.  
 
Figure 2 presents the overlay of the derivated spectrum of matrix absorbance, simulation tablets, 
sample tablets and tranexamic acid standard. This measurement was done to investigate whether the 
active compound spectrum was disturbed by other tablet’s ingredient or not. Then, the figure proofs 
that the spectrum is not influenced by matrix's components.    
 
Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256  
The performance of … (Nugrahani  and  Auli ) 
 
 
 
 
17 
 
 
 
 
Figure 2 . The overlay of derivated spectrum of matrix absorbance, simulation tablets, sample 
tablets and tranexamic acid standard 
 
Next, a calibration curve then  was composed using  the  data  obtained from a series of 
measurement  of  derivated  absorbance’s AUC as listed in Table II. 
 
Table II.  The series concentration series of tranexamic acid standard with AUC 
  
Concentration of tranexamic 
acid (%w/w) 
Mean AUC at wavelength 
1511.08-1573.63 cm
-1
 
0.5 0.0030±0.0003 
0.75 0.0060±0.0002 
1 0.0092±0.0002 
1.25 0.0128±0.0005 
1.5 0.0163±0.0009 
1.75 0.0198±0.0006 
Linearity 0.9994 
  
 
The calibration curve yielded is shown in Figure3, which show a good linearity (r> 0.9996). 
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Figure 3. The linearity between concentration tranexamic acid standard to AUC derivate 
absorbance 
 
Furthermore, the accuracy also has been checked to the 3 concentrations, with the result shown 
in Table III. The recovery values were very good and appropriated to the requirement (ICH, 2005).   
 
Table III. Data of tranexamic acid standard accuracy test with FTIR method 
 
Concentration  AUC (1511.08- Mean AUC Theoritic Recovery (%) 
(%) 1573.63 cm
-1
)  AUC   
80 
0.0065 
0.0068 ±0.0003 0.0068 100.0178 0.0068 
0.0070 
100 
0.0093 
0.0095 ±0.0001 0.0095 100.0130 0.0096 
0.0095 
120 
0.0120 
0.0121 ±0.0001 0.0122 98.9528 0.0121 
0.0121 
     
 
Intra and inter day precision test also have been performed to ensure the quality of this method, 
with the measurement yield shown in Table IV and V. All the data in both table supported the 
feasibility of the method.  
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Table IV. Data of tranexamic acid standard intra-day precision test with FTIR method 
 
No 
AUC (1511.08-1573.63 cm
-1
) 
DAY 1 DAY 2 DAY 3 
1 0.0093 0.0092 0.0094 
2 0.0096 0.0096 0.0097 
3 0.0095 0.0093 0.0094 
4 0.0097 0.0094 0.0096 
5 0.0098 0.0093 0.0095 
6 0.0098 0.0093 0.0096 
Mean 0.0096±0.0002 0.0093±0.0001 0.0095±0.0001 
%SBR 1.9509 1.4942 1.3374 
%Recovery 101.5982 98.5789 100.7846 
 
Table V.  Data of tranexamic acid standard inter-day precision test with FTIR method 
 
Day- AUC (1511.08-1573.63 cm
-1
) 
1 0.0096 ± 0.0002 
2 0.0093 ± 0.0001 
3 0.0095 ± 0.0001 
Mean 0.0095 ± 0.0001 
% SBR 1.5579 
  
Limit detection (LOD) and quantization limit (LOQ)  
Calculation of the limit detection and quantification is by the formula: LOD = 3 (Sy/x) / b = 
0.0531% w/w; LOQ = 10 (Sy/x) / b = 0.1770% w/w. Thus, the lowest detectable analytical 
concentration was 0.0531% w/w, and the smallest quantitative concentration was 0.1770% w/w. 
 
Range  
The range produces linear data and fulfill the validation acceptance test requirements with the 
range of 0.5-1.75% w/w. Based on the validation test; the developed method has investigated to be 
fulfilled the validation requirements. Then, it can be determined to measure the tranexamic acid level 
of tablet dosage forms obtained from the market.   
  
Determination of tranexamic acid tablet content using FTIR  
The determination of the content is conducted by taking 20 tablet samples that have been 
weighted, subsequent crushed homogeneously. A few amounts of tranexamic acid tablets after 
crushed, was prepared to the next analysis by added with KBr and pressed. Six pellets yielded then 
were measured in FTIR. The experiment showed that the content average of the tablet was 101.503 ± 
0.016. The requirement of tranexamic acid levels in the tablets is 95-105% (BP, 2009), so that sample 
has met the criteria required by British Pharmacopeia. The data is shown in Table VI. 
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Table VI. Data tranexamic acid content in tablet sample with FTIR method 
 
 
 
 
 
 
     
 
 
Tranexamic acid derivatization using colorimetry (UV-Vis Spectrophotometry)  
FTIR method then was compared to the colorimetry which has been reported before (Anshari et 
al., 2005; Arayne et al., 2008). Due to the very low absorption and UV sensitivity, tranexamic acid 
was derivated with ninhydrin was selected as the chromophore provider reagent. In the alkaline 
medium, this substance converts to O-carboxyphenylglioxine, then is reduced to 2-hydroxindan-1,3-
dione. The primary aliphatic amino group of the drug is reacted with this reagent in a pH 7 acetate 
buffer through the deamination-oxidation, which followed by the reduction of ninhydrin. The 
maximum color intensity will be yielded  after 30 min heating in the waterbath. This reaction will 
produce Ruhemann's purple solution, which absorbs a maximum wavelength of 559 nm (Anshari et 
al., 2005; Arayne et al., 2008). 
 
Verification of the colorimetry method 
Specificity test was performed by overlaying between the matrix spectrum and the tranexamic 
acid standard. Based on the spectrum below, it can be seen that the presence of the matrix does not 
interfere with the peak of the tranexamic. Therefore, this method was set specific in the testing of 
tranexamic acid.  The absorbance curve of the active compound is shown in Figure 4. 
 
                                               
 
Figure 4. Overlay of spectrum tranexamic acid and matrix 
  
Linearity was determined by measuring the absorbance of tranexamic acid derivatives at six 
different concentrations with a range of 3-25 μg / mL. The analysis was performed at a maximum 
wavelength of 559 nm; each concentration was measured three times. The concentrations were plotted 
to absorbances. Linear regression equation yielded was y = 0.0336x - 0.1087 with a correlation 
regression (r) = 0.9992. The value of coefficient variance, Vx0, was calculated = 0.5307%. Based on 
these results, the values of r was > 0.999 and the Vx0 more than 2%. These results indicate that the 
Tablet Weight AUC Mean  Content (%) 
  AUC  
719.725 ± 2.6103 
0.0094 
0.0097 ± 
0.0006 
101.503 0.0103 
0.0093 
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method has fulfilled the linearity requirement. Furthermore, the accuracy and precision, both inter- and 
intra-day also were checked. All the parameters showed the good result and met with requirements.    
 
Determination of tranexamic acid tablet content with colorimetry 
Twenty tablets of a tranexamic acid product were used as the sample for tested the method 
performance. Each tablet was weighed and then the average of 20 tablets was calculated. Next it was 
used to make the sample solution by coupled with ninhydrin. Furthermore, it was analyzed using 
spectrophotometry visible (colorimetry), which have been verified before. Then, the resulting content 
determination was analyzed in accordance with the requirements in the compendia. The result was 
100.09 ± 0.014%, where the requirement of tranexamic acid level is 95-105% (BP, 2009). Therefore, it 
can be concluded that tablets have met the criteria required by British pharmacopeia. 
 
Methods comparison  
Independent t-test between FTIR and colorimetry methods 
This test is applied if the data analyst aims to find out whether 2 groups of samples differ in a 
particular variable. 
Table VII. T-test between FTIR and colorimetry 
 
 
 
 
 
 
 
 
Note :  
Ho = there is no significant difference 
HA = there are significant differences 
p = 0.5166 
p > 0.05 
Ho accepted 
 
From the statistical calculation of Ho (null hypothesis), it was proved that there was no 
significant difference between the determination of tranexamic acid level using FTIR with the visible 
spectrophotometry. Furthermore, all of validation parameters such as linearity validation were 
compared. That were accuracy, intra day and inter day precision, timing, cost, simplicity of analysis, 
LOD and LOQ. From the data listed in the Table VIII, it can be seen the almost similar performance, 
except the sensitivity. The FTIR method has a lower sensitivity than the colorimetry, which was 
approximately a hundred times higher.    
 
 
 
 
 
 
 
 
 
 
 
Concentration Tranexamic Acid  Tablet 
FTIR Colorimetry 
99.455 99.636 
106.250 100.959 
98.806 98.644 
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Table VIII. FTIR versus colorimetry parameters 
 
Parameters FTIR Colorimetry 
Linearity (r) 0.9994 0.9992 
Accuration/recovery 
(%)  
98.95-100.017% 99.246-101.432% 
   
Intraday precision 
(%SBR) 
1.95; 1.49; 1.33% 1.183; 0.884; 0.279% 
Interday precision 
(%SBR) 
1.55% 0.239; 1.224; 1.319% 
LOD and LOQ LOD = 0.0531% w/w 
(531 ppm) 
LOQ = 0.1770% w/w 
(1770 ppm) 
 
LOD = 0.7345 μg/mL (0.7345 
ppm) 
LOQ  = 2.448 μg/mL (2.448 ppm) 
 
Time 1 hour 8 hours 
Cost Total = IDR 130.000 Total = IDR 366.000 
 
Simplicity Very easy and simple Easy but not simple due to 
derivatitation involved heating 
step. 
 
 
However, the FTIR method shows the easier, simpler, faster and cheaper than its opponent. 
These advantages are gained from of the simplicity of sample preparation, because the extraction 
should not be needed. Without separation step and less solvent using, the cost and time of 
measurement can be reduced. On the other hand, it will be more environmental friendly. Table VIII 
also explains the cost of both methods, which shows that FTIR method needed third part only, 
compared to the colorimetry. Moreover, the time for analysis was much more reduced, until one eight 
from the opponent. FTIR method also showed lower sensitivity than colorimetry, which means it can 
measure the sample at very low concentration than colorimetry. 
 
CONCLUSION 
FTIR can be used as a newe developed method of determining tranexamic acid levels in tablets 
at 1511.08-1573.63 cm
-1
. This method has been evaluated to meet acceptance validation parameters, 
including specificity, linearity, accuracy, and its precision. 
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